ストックスクリーナーアプリを入手
21.07
0.84%
-0.20
前日終値:
$21.27
開ける：
$21.27
24時間の取引高:
957.47K
Relative Volume:
0.66
時価総額：
$2.58B
収益：
$460.48M
当期純損益:
$142.80M
株価収益率:
17.86
EPS:
1.18
ネットキャッシュフロー:
$221.79M
1週間 パフォーマンス:
-1.39%
1か月 パフォーマンス:
+1.21%
6か月 パフォーマンス:
-15.09%
1年 パフォーマンス:
-3.65%
1日の値動き範囲:
$20.95
$21.74
1週間の範囲:
$20.72
$21.74
52週間の値動き範囲:
$19.05
$26.58
Catalyst Pharmaceuticals Inc Stock (CPRX) Company Profile
名前
Catalyst Pharmaceuticals Inc
セクター
電話
(305) 529-2522
住所
355 ALHAMBRA CIRCLE, CORAL GABLES
CPRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPRX
Catalyst Pharmaceuticals Inc
|
21.06 | 2.60B | 460.48M | 142.80M | 221.79M | 1.18 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.63 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
640.13 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
431.19 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
823.88 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
185.89 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Catalyst Pharmaceuticals Inc Stock (CPRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-02-04 | 開始されました | Robert W. Baird | Outperform |
| 2024-11-18 | 開始されました | Stephens | Overweight |
| 2024-03-14 | 開始されました | Citigroup | Buy |
| 2024-03-07 | 開始されました | BofA Securities | Buy |
| 2023-12-21 | 開始されました | Oppenheimer | Outperform |
| 2022-08-24 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2018-09-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2018-09-07 | 再開されました | Piper Jaffray | Overweight |
| 2016-10-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-04-26 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2014-09-30 | 繰り返されました | ROTH Capital | Buy |
| 2014-09-16 | 繰り返されました | ROTH Capital | Buy |
| 2014-09-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2013-10-21 | 繰り返されました | Aegis Capital | Buy |
| 2013-09-24 | 開始されました | Maxim Group | Buy |
| 2013-09-06 | 繰り返されました | Aegis Capital | Buy |
| 2013-04-18 | 開始されました | Aegis Capital | Buy |
| 2012-08-27 | アップグレード | Rodman & Renshaw | Mkt Perform → Mkt Outperform |
| 2009-10-01 | アップグレード | Merriman | Sell → Neutral |
| 2009-05-29 | ダウングレード | Hapoalim | Neutral → Underperform |
| 2009-05-29 | ダウングレード | Merriman Curhan Ford | Buy → Sell |
| 2008-12-15 | 開始されました | Merriman Curhan Ford | Buy |
| 2007-11-28 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-01-31 | 開始されました | Stifel Nicolaus | Buy |
| 2007-01-05 | 開始されました | First Albany | Buy |
すべてを表示
Catalyst Pharmaceuticals Inc (CPRX) 最新ニュース
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference - The Manila Times
Catalyst Pharma (Nasdaq: CPRX) at Jefferies Healthcare Conference; webcast 2:00 pm GMT - Stock Titan
Momentum divergence signals in Catalyst Pharmaceuticals Inc. chartJuly 2025 Pullbacks & High Yield Stock Recommendations - newser.com
Is Catalyst Pharmaceuticals Inc. (CN2) stock a buy on weakness2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Catalyst Pharmaceuticals (CPRX): Exploring Valuation as Shares Remain Steady and Investors Weigh Long-Term Growth - Yahoo Finance
Can Catalyst Pharmaceuticals Inc. hit a new high this monthEarnings Overview Report & High Return Stock Watch Alerts - newser.com
Will Catalyst Pharmaceuticals Inc. stock split again soon2025 Momentum Check & Daily Stock Momentum Reports - newser.com
What analyst consensus says on Catalyst Pharmaceuticals Inc. stockJuly 2025 Price Swings & Daily Chart Pattern Signal Reports - newser.com
Will Catalyst Pharmaceuticals Inc. (CN2) stock keep high P E multiplesWeekly Loss Report & Consistent Return Investment Signals - newser.com
Is Catalyst Pharmaceuticals Inc. (CN2) stock attractive post correctionPortfolio Growth Summary & Risk Managed Investment Signals - newser.com
Catalyst Pharmaceuticals Inc. recovery potential after sell offWeekly Trade Report & Entry Point Confirmation Alerts - newser.com
What risks investors should watch in Catalyst Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com
Using portfolio simulators with Catalyst Pharmaceuticals Inc. included2025 Key Highlights & High Conviction Investment Ideas - newser.com
Applying Elliott Wave Theory to Catalyst Pharmaceuticals Inc.Earnings Growth Report & Real-Time Volume Analysis - newser.com
Using Bollinger Bands to evaluate Catalyst Pharmaceuticals Inc.Gap Down & Reliable Price Breakout Signals - newser.com
Price momentum metrics for Catalyst Pharmaceuticals Inc. explainedIndex Update & Technical Pattern Based Buy Signals - newser.com
Catalyst Pharmaceuticals, Inc. $CPRX Shares Sold by Moody Aldrich Partners LLC - MarketBeat
Will Catalyst Pharmaceuticals Inc. (CN2) stock sustain uptrend momentumBuy Signal & Community Verified Watchlist Alerts - newser.com
Is Catalyst Pharmaceuticals Inc. stock bottoming outWeekly Stock Recap & Low Risk Entry Point Guides - newser.com
Why global investors buy Catalyst Pharmaceuticals Inc. (CN2) stockStop Loss & Accurate Entry/Exit Alerts - newser.com
Can Catalyst Pharmaceuticals Inc. (CN2) stock surprise with quarterly resultsAnalyst Downgrade & Stock Portfolio Risk Control - newser.com
How rising interest rates impact Catalyst Pharmaceuticals Inc. stockPortfolio Update Summary & Safe Capital Investment Plans - newser.com
Yorktown Management & Research Co Inc Trims Stake in Catalyst Pharmaceuticals, Inc. $CPRX - MarketBeat
Catalyst Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Earnings Preview: Catalyst Pharmaceutical (CPRX) Q3 Earnings Expected to Decline - Yahoo Finance
Catalyst Pharmaceuticals (CPRX) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Catalyst Pharmaceuticals Inc (CPRX) 財務データ
収益
当期純利益
現金流量
EPS
0.21%
1.56%
大文字化:
|
ボリューム (24 時間):